Skip to main content
. 2022 Dec 19;12:21882. doi: 10.1038/s41598-022-25938-0

Table 4.

Numbers of patients with constant cardiovascular medication at the last two study visits.

Cardiovascular medication at the last two visits of participation n (%)
Antiplatelet agents 450 (24.8%)
Beta-blockers 411 (22.6%)
Lipid-lowering drugs 435 (23.9%)
RAAS inhibitors 786 (43.3%)
Diuretics 531 (29.2%)

RAAS = Renin–angiotensin–aldosterone system. For details see Methods. Percentages refer to the total study population (n = 1817).